76Bio Overview
- Year Founded
-
2020
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Out of Business
76Bio General Information
Description
Developer of a biotechnology platform designed to degrade or break down unneeded proteins. The company offers targeted protein degraders, enabling healthcare organizations to treat patients suffering from life-threatening diseases with the next generation of targeted protein degradation therapies.
Contact Information
Website
www.76bio.comCorporate Office
- 40 Guest Street
- Boston, MA 01235
- United States
Corporate Office
- 40 Guest Street
- Boston, MA 01235
- United States
76Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 29-Jan-2025 | Completed | Out of Business | |||
| 3. Early Stage VC | 14-Feb-2023 | Completed | Generating Revenue | |||
| 2. Seed Round | 07-Jan-2022 | $10M | $10M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
76Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
76Bio Patents
76Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024081913-A1 | Dual-specific bifunctional fusion proteins for ubiquitin-mediated degradation | Inactive | 14-Oct-2022 | ||
| WO-2023215839-A1 | Bifunctional fusion proteins for ubiquitin-mediated degradation | Inactive | 06-May-2022 |
76Bio Signals
76Bio Investments (1)
76Bio’s most recent deal was a Seed Round with Axelyf for . The deal was made on 29-Aug-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Axelyf | 29-Aug-2025 | Seed Round | Drug Discovery |
76Bio FAQs
-
When was 76Bio founded?
76Bio was founded in 2020.
-
Where is 76Bio headquartered?
76Bio is headquartered in Boston, MA.
-
What is the size of 76Bio?
76Bio has 9 total employees.
-
What industry is 76Bio in?
76Bio’s primary industry is Drug Discovery.
-
Is 76Bio a private or public company?
76Bio is a Private company.
-
What is 76Bio’s current revenue?
The current revenue for 76Bio is .
-
How much funding has 76Bio raised over time?
76Bio has raised $22.2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process